Cassava Sciences Inc (SAVA)
20.35
-0.75
(-3.55%)
USD |
NASDAQ |
May 10, 14:15
Cassava Sciences Cash from Operations (TTM): -82.02M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -82.02M |
| September 30, 2023 | -81.03M |
| June 30, 2023 | -76.05M |
| March 31, 2023 | -67.24M |
| December 31, 2022 | -77.51M |
| September 30, 2022 | -64.18M |
| June 30, 2022 | -57.40M |
| March 31, 2022 | -51.42M |
| December 31, 2021 | -30.20M |
| September 30, 2021 | -23.38M |
| June 30, 2021 | -10.79M |
| March 31, 2021 | -6.494M |
| December 31, 2020 | -5.382M |
| September 30, 2020 | -4.796M |
| June 30, 2020 | -3.355M |
| March 31, 2020 | -3.104M |
| December 31, 2019 | -2.514M |
| September 30, 2019 | -2.49M |
| June 30, 2019 | -3.196M |
| March 31, 2019 | -3.731M |
| December 31, 2018 | -4.77M |
| September 30, 2018 | -5.642M |
| June 30, 2018 | -6.357M |
| March 31, 2018 | -8.428M |
| December 31, 2017 | -8.237M |
| Date | Value |
|---|---|
| September 30, 2017 | -9.831M |
| June 30, 2017 | -10.47M |
| March 31, 2017 | -10.54M |
| December 31, 2016 | -12.23M |
| September 30, 2016 | -12.75M |
| June 30, 2016 | -12.37M |
| March 31, 2016 | -11.05M |
| December 31, 2015 | -9.053M |
| September 30, 2015 | -8.068M |
| June 30, 2015 | -7.33M |
| March 31, 2015 | -7.973M |
| December 31, 2014 | -9.549M |
| September 30, 2014 | -8.44M |
| June 30, 2014 | -8.587M |
| March 31, 2014 | -7.797M |
| December 31, 2013 | -6.947M |
| September 30, 2013 | -7.347M |
| June 30, 2013 | -6.825M |
| March 31, 2013 | -6.974M |
| December 31, 2012 | -7.171M |
| September 30, 2012 | -6.126M |
| June 30, 2012 | -6.002M |
| March 31, 2012 | -5.599M |
| December 31, 2011 | -0.26M |
| September 30, 2011 | -2.79M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-82.02M
Minimum
Dec 2023
-2.49M
Maximum
Sep 2019
-34.34M
Average
-23.38M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
| Amylyx Pharmaceuticals Inc | 11.92M |
| Clearside Biomedical Inc | -18.14M |
| Lantern Pharma Inc | -14.35M |
| NovaBay Pharmaceuticals Inc | -4.131M |
| Palatin Technologies Inc | -26.54M |